标题 |
NRI and SIRI are the optimal combinations for prognostic risk stratification in patients with non-small cell lung cancer after EGFR-TKI therapy
NRI和SIRI是EGFR-TKI治疗后非小细胞肺癌患者预后风险分层的最佳组合
|
网址 | |
DOI | |
其它 |
期刊:Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 作者:Liu X; Wang P; Liu G 出版日期:2024/09/20 |
求助人 | |
下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |